The unphosphorylated, closed form of ezrin binds to RNA to maintain a metastatic phenotype in osteosarcoma cells
Science Signaling · 2026
DOI: 10.1126/scisignal.ady8367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2026. Verfasst von Emre Deniz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA. Hauptthemen laut MEDLINE: Cytoskeletal Proteins, Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Children’s Cancer Foundation.
Abstract (Originalsprache)
Ezrin is a cytoplasmic protein that can exist in multiple conformations that are regulated by phosphorylation at Thr 567 . The phosphorylated, open form of ezrin generally has been considered the active form because it translocates to the plasma membrane. In contrast, the unphosphorylated, closed form of ezrin is sequestered in the cytoplasm and is considered inactive, although it directly interacts with cytoplasmic RNA binding proteins. Here, we found that the closed form of ezrin is itself an RNA binding protein with biological activity. The abundance of ezrin correlated with that of RBPs in human osteosarcoma samples. Purified recombinant ezrin protein engineered to maintain a closed conformation (rEZRIN-T567A) directly bound RNA, with greatest affinity for guanine-rich sequences and RNA G-quadruplexes (G4 RNAs). Expressing closed ezrin in ezrin-null osteosarcoma cells restored the transcriptomic and proteomic profiles. Closed ezrin bound to endogenous mRNAs associated with pathways related to RNA processing and splicing, DNA maintenance, and cellular metabolism. In zebrafish, expression of closed ezrin rescued the metastatic capability of ezrin-null osteosarcoma xenografts. Our findings demonstrate that the closed conformation of ezrin—previously thought to be inactive—can directly bind RNA, regulate transcription and translation, and contribute to a metastatic phenotype in osteosarcoma cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA.
- Department of Biology, College of Arts & Sciences, Georgetown University, Washington, DC 20057, USA.
- Department of Pathology, Georgetown University Medical Center, Washington, DC 20057, USA.
- Department of Pathology, University of Colorado Anschutz, Aurora, CO 80045, USA.
- Walter Johnson High School, Bethesda, MD 20814, USA.
ORCID-Profile: Emre Deniz, Purushottam B Tiwari, Eric Glasgow, Brent T Harris, Chunyan Hou, Junfeng Ma, Jeffrey A Toretsky, Aykut Üren
Förderung
- NCI NIH HHS
- Children’s Cancer Foundation
Zitieren
APA
Deniz, E., Tiwari, P., Tiwari, P. B., Glasgow, E., Harris, B. T., Tiwari, A., Hou, C., Ma, J., Toretsky, J. A., & Üren, A. (2026). The unphosphorylated, closed form of ezrin binds to RNA to maintain a metastatic phenotype in osteosarcoma cells. Science Signaling. https://doi.org/10.1126/scisignal.ady8367
Vancouver
Deniz E, Tiwari P, Tiwari PB, Glasgow E, Harris BT, Tiwari A, et al. The unphosphorylated, closed form of ezrin binds to RNA to maintain a metastatic phenotype in osteosarcoma cells. Science Signaling. 2026. doi:10.1126/scisignal.ady8367
BibTeX
@article{Deniz2026,
author = {Deniz, Emre and Tiwari, Prakriti and Tiwari, Purushottam B and Glasgow, Eric and Harris, Brent T and Tiwari, Anup and Hou, Chunyan and Ma, Junfeng and Toretsky, Jeffrey A and Üren, Aykut},
title = {The unphosphorylated, closed form of ezrin binds to RNA to maintain a metastatic phenotype in osteosarcoma cells},
journal = {Science Signaling},
year = {2026},
doi = {10.1126/scisignal.ady8367}
}
EUVIMED